Sanofi India Limited (BOM:500674)
3,522.25
+56.75 (1.64%)
At close: Apr 15, 2026
Sanofi India Revenue
In the year 2025, Sanofi India had annual revenue of 18.37B INR, down -8.73%. Sanofi India had revenue of 4.20B in the quarter ending December 31, 2025, a decrease of -18.47%.
Revenue
18.37B
Revenue Growth
-8.73%
P/S Ratio
4.41
Revenue / Employee
16.75M
Employees
1,097
Market Cap
81.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.37B | -1.76B | -8.73% |
| Dec 31, 2024 | 20.13B | 171.00M | 0.86% |
| Dec 31, 2023 | 19.96B | -7.74B | -27.94% |
| Dec 31, 2022 | 27.70B | -1.87B | -6.31% |
| Dec 31, 2021 | 29.57B | 547.00M | 1.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Granules India | 50.92B |
| AstraZeneca Pharma India | 21.77B |
| Caplin Point Laboratories | 20.92B |
| FDC Limited | 20.78B |
| Viyash Scientific | 18.17B |
| Rubicon Research | 15.98B |
| Procter & Gamble Health | 13.49B |
Sanofi India News
- 6 weeks ago - Sanofi India Ltd (BOM:500674) Q4 2026 Earnings Call Highlights: Navigating Growth and ... - GuruFocus
- 6 weeks ago - Q4 2026 Sanofi India Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Sanofi India Ltd (BOM:500674) Q3 2026 Earnings Call Highlights: Strategic Shifts and Financial Gains - GuruFocus
- 5 months ago - Q3 2026 Sanofi India Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Sanofi India Q2 Results: Revenue falls 9.3% YoY to Rs 475.4 crore, net profit down 7.5% - Business Upturn
- 6 months ago - Sanofi India appoints Deepak Arora as new Managing Director, effective October 27, 2025 - Business Upturn
- 9 months ago - Sanofi India shares fall over 2% as Q1 revenue drops 12.4% YoY to Rs 406 crore, Ebitda down 18% - Business Upturn
- 9 months ago - Emcure and Sanofi India announce exclusive partnership to distribute oral anti-diabetic drugs in India - Business Upturn